Health Care Resource Utilization in Inflammatory Bowel Disease
Overview
Authors
Affiliations
Background & Aims: The aim of this study was to quantify temporal changes in health care utilization by a population-based cohort of IBD.
Methods: By using the University of Manitoba IBD Epidemiology Database we assessed utilization of outpatient and hospital services, estimating relative risk (RR) of utilization for IBD cases compared with a matched cohort of non-IBD controls and for CD versus UC. We tested differences in utilization between prevalence cohorts 1990-1991 and 2000-2001. Also, utilization of the 1987-1988 incidence cohort was followed forward 15 years from diagnosis. The probability, intensity, and volume of utilization were estimated.
Results: In 2000-2001, IBD patients compared with controls were more likely to have an outpatient visit (RR, 1.18; 95% confidence interval [CI], 1.17-1.19) and an overnight hospital stay (RR, 2.32; 95% CI, 2.16-2.49). CD cases were more likely than UC cases to be hospitalized (RR, 1.26; 95% CI, 1.11-1.43) and had a greater number of outpatient visits. From 1990-1991 to 2000-2001, IBD cases experienced a significant decrease in the likelihood of an outpatient surgical visit relative to non-IBD controls (P < .05), and for those cases who were hospitalized, CD cases tended to be less likely than UC cases to experience IBD-specific inpatient surgery (P < .07). Of the 1987-1988 incidence cohort, 80% of admissions that occurred during the follow-up period were during the first 5 years after diagnosis.
Conclusions: In 2000-2001, health care utilization continued to be higher in IBD versus controls and CD versus UC; however, the gap in costly service utilization appeared to narrow between the latter pair.
Zhen J, Simoneau M, Sharma P, Germain P, Watier-Levesque P, Othman A J Can Assoc Gastroenterol. 2024; 7(6):423-430.
PMID: 39679104 PMC: 11638002. DOI: 10.1093/jcag/gwae029.
Racial and Ethnic Disparities in Inflammatory Bowel Disease.
Borum M Gastroenterol Hepatol (N Y). 2023; 19(5):281-283.
PMID: 37799459 PMC: 10548245.
Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland.
Markiewicz-Loskot G, Chlebowczyk W, Holecki T Children (Basel). 2023; 10(7).
PMID: 37508609 PMC: 10378369. DOI: 10.3390/children10071112.
Systematic Review of Self-Management Assessment Tools for Children With Inflammatory Bowel Disease.
Vernon-Roberts A, Rouse E, Gearry R, Day A JPGN Rep. 2023; 2(3):e075.
PMID: 37205965 PMC: 10191491. DOI: 10.1097/PG9.0000000000000075.
Impact of Digital Health Monitoring in the Management of Inflammatory Bowel Disease.
Zhen J, Marshall J, Nguyen G, Atreja A, Narula N J Med Syst. 2021; 45(2):23.
PMID: 33449213 PMC: 7808932. DOI: 10.1007/s10916-021-01706-x.